Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options

J Clin Oncol. 2011 Jun 1;29(16):e473-6. doi: 10.1200/JCO.2010.32.8351. Epub 2011 Mar 21.

Authors

Heidy C J Jaspers¹, Berit M Verbist, Rafke Schoffelen, Vera Mattijssen, Piet J Slootweg, Winette T A van der Graaf, Carla M L van Herpen

Affiliation

¹ Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

PMID: 21422415
DOI: 10.1200/JCO.2010.32.8351

No abstract available

Publication types

Case Reports

MeSH terms

Anilides / therapeutic use*
Antineoplastic Agents / therapeutic use
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary
Brain Neoplasms / drug therapy
Brain Neoplasms / secondary
Carcinoma, Ductal / drug therapy*
Carcinoma, Ductal / metabolism
Carcinoma, Ductal / secondary
Humans
Lymphatic Metastasis / pathology
Magnetic Resonance Imaging
Male
Middle Aged
Nitriles / therapeutic use*
Receptors, Androgen / metabolism*
Salivary Ducts / pathology*
Salivary Gland Neoplasms / drug therapy*
Salivary Gland Neoplasms / metabolism
Salivary Gland Neoplasms / pathology
Tosyl Compounds / therapeutic use*

Substances

Anilides
Antineoplastic Agents
Nitriles
Receptors, Androgen
Tosyl Compounds
bicalutamide